Invest in evidence-based decision making

Help ensure that every dollar spent on vaccination delivers maximum impact — by strengthening the economic evidence behind global and national decisions. 

Why this matters 

Immunization remains one of the most cost-effective health interventions — but the environment for decision-making is rapidly changing. 

Over the past year, reductions in donor funding have placed increasing pressure on countries to do more with less. At the same time, the space for evidence-based decision-making is becoming more fragile, especially in immunization, with growing risks that resource allocation decisions are not consistently guided by the best available data. 

In this context, robust economic evidence to inform optimized resource allocation is more important than ever. 

What you’re investing in 

Immunization Economics exists to ensure that decisions about vaccination — what to fund, how to prioritize, and how to design programs — are grounded in robust evidence. 

We connect researchers, policymakers, and practitioners across over 115 countries to ensure that economic evidence is produced and used to shape real-world decisions.  

With your support, we: 

  • Strengthen decision-making 
    Equip governments and partners with economic evidence to inform resource allocation decisions for vaccination programs in low- and middle-income countries  
  • Translate evidence into policy-relevant insights 
    Interpret and synthesize complex economic evidence into clear insights to guide policy development and resource prioritization  
  • Build sustainable capacity 
    Support researchers and policymakers to generate and use economic evidence to support immunization programs  
  • Connect key decision-makers 
    Convene a global network of 3,600+ experts across governments, donors, academia, and NGOs to shape research priorities and inform policy and investment decisions 
“Countries need to build up domestic capacity in generating and using economic evidence. Immunization Economics is an invaluable platform for that.”

Rose Jalang’o, Head of the National Vaccines & Immunization Program, Kenya

Invest in ImmunizationEconomics.org now to support evidence-based decision making and help improve immunization outcomes in low- and middle-income countries